378 related articles for article (PubMed ID: 10519554)
1. Cytochrome P450 2C is an EDHF synthase in coronary arteries.
Fisslthaler B; Popp R; Kiss L; Potente M; Harder DR; Fleming I; Busse R
Nature; 1999 Sep; 401(6752):493-7. PubMed ID: 10519554
[TBL] [Abstract][Full Text] [Related]
2. Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries.
Fleming I; Michaelis UR; Bredenkötter D; Fisslthaler B; Dehghani F; Brandes RP; Busse R
Circ Res; 2001 Jan; 88(1):44-51. PubMed ID: 11139472
[TBL] [Abstract][Full Text] [Related]
3. Nifedipine increases cytochrome P4502C expression and endothelium-derived hyperpolarizing factor-mediated responses in coronary arteries.
Fisslthaler B; Hinsch N; Chataigneau T; Popp R; Kiss L; Busse R; Fleming I
Hypertension; 2000 Aug; 36(2):270-5. PubMed ID: 10948089
[TBL] [Abstract][Full Text] [Related]
4. The coronary endothelium-derived hyperpolarizing factor (EDHF) stimulates multiple signalling pathways and proliferation in vascular cells.
Fleming I; Fisslthaler B; Michaelis UR; Kiss L; Popp R; Busse R
Pflugers Arch; 2001 Jul; 442(4):511-8. PubMed ID: 11510882
[TBL] [Abstract][Full Text] [Related]
5. EDHF: a cytochrome P450 metabolite in coronary arteries.
Fisslthaler B; Fleming I; Busse R
Semin Perinatol; 2000 Feb; 24(1):15-9. PubMed ID: 10709852
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 2C expression and EDHF-mediated relaxation in porcine coronary arteries is increased by cortisol.
Bauersachs J; Christ M; Ertl G; Michaelis UR; Fisslthaler B; Busse R; Fleming I
Cardiovasc Res; 2002 Jun; 54(3):669-75. PubMed ID: 12031713
[TBL] [Abstract][Full Text] [Related]
7. A transferable, beta-naphthoflavone-inducible, hyperpolarizing factor is synthesized by native and cultured porcine coronary endothelial cells.
Popp R; Bauersachs J; Hecker M; Fleming I; Busse R
J Physiol; 1996 Dec; 497 ( Pt 3)(Pt 3):699-709. PubMed ID: 9003555
[TBL] [Abstract][Full Text] [Related]
8. Cyclic stretch enhances the expression and activity of coronary endothelium-derived hyperpolarizing factor synthase.
Fisslthaler B; Popp R; Michaelis UR; Kiss L; Fleming I; Busse R
Hypertension; 2001 Dec; 38(6):1427-32. PubMed ID: 11751730
[TBL] [Abstract][Full Text] [Related]
9. Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation.
Bauersachs J; Hecker M; Busse R
Br J Pharmacol; 1994 Dec; 113(4):1548-53. PubMed ID: 7889312
[TBL] [Abstract][Full Text] [Related]
10. High glucose impairs EDHF-mediated dilation of coronary arterioles via reduced cytochrome P450 activity.
Tsai SH; Hein TW; Kuo L; Yang VC
Microvasc Res; 2011 Nov; 82(3):356-63. PubMed ID: 21983453
[TBL] [Abstract][Full Text] [Related]
11. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals.
Hecker M; Bara AT; Bauersachs J; Busse R
J Physiol; 1994 Dec; 481 ( Pt 2)(Pt 2):407-14. PubMed ID: 7738833
[TBL] [Abstract][Full Text] [Related]
12. Apamin-sensitive, non-nitric oxide (NO) endothelium-dependent relaxations to bradykinin in the bovine isolated coronary artery: no role for cytochrome P450 and K+.
Drummond GR; Selemidis S; Cocks TM
Br J Pharmacol; 2000 Feb; 129(4):811-9. PubMed ID: 10683206
[TBL] [Abstract][Full Text] [Related]
13. Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BK(Ca) channels.
Archer SL; Gragasin FS; Wu X; Wang S; McMurtry S; Kim DH; Platonov M; Koshal A; Hashimoto K; Campbell WB; Falck JR; Michelakis ED
Circulation; 2003 Feb; 107(5):769-76. PubMed ID: 12578883
[TBL] [Abstract][Full Text] [Related]
14. Antisense oligonucleotides against cytochrome P450 2C8 attenuate EDHF-mediated Ca(2+) changes and dilation in isolated resistance arteries.
Bolz SS; Fisslthaler B; Pieperhoff S; De Wit C; Fleming I; Busse R; Pohl U
FASEB J; 2000 Feb; 14(2):255-60. PubMed ID: 10657982
[TBL] [Abstract][Full Text] [Related]
15. Endothelium-dependent relaxation and hyperpolarization in guinea-pig coronary artery: role of epoxyeicosatrienoic acid.
Eckman DM; Hopkins N; McBride C; Keef KD
Br J Pharmacol; 1998 May; 124(1):181-9. PubMed ID: 9630358
[TBL] [Abstract][Full Text] [Related]
16. Endothelium-derived hyperpolarizing factor, but not nitric oxide, is reversibly inhibited by brefeldin A.
Bauersachs J; Fleming I; Scholz D; Popp R; Busse R
Hypertension; 1997 Dec; 30(6):1598-605. PubMed ID: 9403589
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 epoxygenases as EDHF synthase(s).
Fleming I
Pharmacol Res; 2004 Jun; 49(6):525-33. PubMed ID: 15026030
[TBL] [Abstract][Full Text] [Related]
18. Bioassay of an endothelium-derived hyperpolarizing factor from bovine coronary arteries: role of a cytochrome P450 metabolite.
Gebremedhin D; Harder DR; Pratt PF; Campbell WB
J Vasc Res; 1998; 35(4):274-84. PubMed ID: 9701712
[TBL] [Abstract][Full Text] [Related]
19. Role of cytochrome P450-dependent transient receptor potential V4 activation in flow-induced vasodilatation.
Loot AE; Popp R; Fisslthaler B; Vriens J; Nilius B; Fleming I
Cardiovasc Res; 2008 Dec; 80(3):445-52. PubMed ID: 18682435
[TBL] [Abstract][Full Text] [Related]
20. Proinflammatory mediators chronically downregulate the formation of the endothelium-derived hyperpolarizing factor in arteries via a nitric oxide/cyclic GMP-dependent mechanism.
Kessler P; Popp R; Busse R; Schini-Kerth VB
Circulation; 1999 Apr; 99(14):1878-84. PubMed ID: 10199886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
